Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
When would you consider an all-oral regimen for patients with Whipple's disease instead of the typical parenteral treatment with ceftriaxone or meropenem followed by oral TMP/SMX?
Moos V, et al., PMID 39978372
Related Questions
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
What infectious differentials should be considered for a patient with intractable erythema nodosum that is non-responsive to acyclovir and steroids?
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
Do you routinely obtain a TEE or vascular imaging in a patient with non-typhoid salmonella bacteremia without persistent bacteremia?
Do you give lifelong anti fungal therapy or a set time period of anti fungal therapy to patients who have vertebral hardware infection with some residual hardware that cannot be removed?
Do you prefer vancomycin or daptomycin for gram-positive coverage in culture-negative prosthetic valve endocarditis considering both Corynebacterium and Enterococcus are notable possible pathogens?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
How do you manage gram-negative bacteremia in a patient with an aortic bypass graft, for whom there is low clinical suspicion for active graft infection?
For patients with spinal hardware infections, in what circumstances do you recommend 12 weeks over 6 weeks of antimicrobial therapy?
